Bioinvent International Ab Stock Cash And Equivalents
| BINV Stock | SEK 26.00 0.70 2.77% |
BioInvent International AB fundamentals help investors to digest information that contributes to BioInvent International's financial success or failures. It also enables traders to predict the movement of BioInvent Stock. The fundamental analysis module provides a way to measure BioInvent International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioInvent International stock.
BioInvent |
BioInvent International AB Company Cash And Equivalents Analysis
BioInvent International's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current BioInvent International Cash And Equivalents | 28.46 M |
Most of BioInvent International's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioInvent International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, BioInvent International AB has 28.46 M in Cash And Equivalents. This is 96.53% lower than that of the Biotechnology sector and 93.63% lower than that of the Health Care industry. The cash and equivalents for all Sweden stocks is 98.95% higher than that of the company.
BioInvent Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioInvent International's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioInvent International could also be used in its relative valuation, which is a method of valuing BioInvent International by comparing valuation metrics of similar companies.BioInvent International is currently under evaluation in cash and equivalents category among related companies.
BioInvent Fundamentals
| Return On Equity | -0.0274 | |||
| Return On Asset | -0.0192 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 1.16 B | |||
| Shares Outstanding | 65.8 M | |||
| Shares Owned By Insiders | 11.10 % | |||
| Shares Owned By Institutions | 57.02 % | |||
| Price To Earning | (9.49) X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 19.38 M | |||
| Gross Profit | 19.38 M | |||
| EBITDA | (263.32 M) | |||
| Net Income | (278.44 M) | |||
| Cash And Equivalents | 28.46 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 21.53 M | |||
| Debt To Equity | 22.00 % | |||
| Current Ratio | 2.73 X | |||
| Book Value Per Share | 25.92 X | |||
| Cash Flow From Operations | (245.84 M) | |||
| Earnings Per Share | (4.55) X | |||
| Target Price | 81.0 | |||
| Number Of Employees | 93 | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.99 B | |||
| Total Asset | 1.45 B | |||
| Working Capital | 28 M | |||
| Current Asset | 56 M | |||
| Current Liabilities | 28 M | |||
| Z Score | 55.2 | |||
| Net Asset | 1.45 B |
About BioInvent International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioInvent International AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioInvent International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioInvent International AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BioInvent International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioInvent International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioInvent International will appreciate offsetting losses from the drop in the long position's value.Moving together with BioInvent Stock
| 0.62 | ATCO-A | Atlas Copco AB | PairCorr |
Moving against BioInvent Stock
| 0.83 | SSAB-B | SSAB AB | PairCorr |
The ability to find closely correlated positions to BioInvent International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioInvent International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioInvent International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioInvent International AB to buy it.
The correlation of BioInvent International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioInvent International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioInvent International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioInvent International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioInvent International AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for BioInvent Stock analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |